Related Experiment Video
Updated: Jun 29, 2025

03:40
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
456
Yingxiang Acupoint Embedding Improves Mucosal Barrier Function in Rats with Local Allergic Rhinitis
Feng Xiang1, Hui Zhang2, Ran Jing2
1Chengdu University of Traditional Chinese Medicine, Chengdu, China, 2280646803@qq.com.
International Archives of Allergy and Immunology
|April 8, 2024
Summary
Acupoint catgut embedding (AE) enhances nasal mucosal barrier function in local allergic rhinitis (LAR) by reducing inflammation and improving tight junctions. This treatment offers a potential therapeutic strategy for LAR.
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Epithelial barrier disruption is a key factor in various diseases.
- Previous studies indicated acupoint catgut embedding (AE) benefits tight junction proteins (TJs) in allergic rhinitis.
- The efficacy of AE on epithelial barriers in local allergic rhinitis (LAR) was yet to be determined.
Purpose of the Study:
- To investigate the effects of AE on the epithelial barrier function in a rat model of LAR.
- To elucidate the underlying mechanisms, including inflammation, endoplasmic reticulum stress (ERS), and TJ expression.
Main Methods:
- Establishment of a rat model for LAR.
- Treatment groups included control, LAR, false AE + LAR, AE + LAR, capsaicin + LAR, and tunicamycin + AE + LAR.
- Assessment involved behavioral observation, ELISA, IgE detection, permeability tests, histology, PCR, Western blot, and immunofluorescence.
Main Results:
- AE significantly improved LAR symptoms and nasal mucosal pathology.
- AE reduced inflammatory cytokines (IL-4, IL-5, IL-13) in nasal lavage fluid.
- AE decreased Substance P (SP) expression, inhibited ERS, increased TJ expression, and reduced nasal mucosal permeability.
Conclusions:
- AE effectively enhances nasal mucosal barrier function in LAR.
- The mechanism involves reducing SP, inhibiting ERS, and increasing TJ expression.
- AE presents a promising therapeutic approach for improving epithelial barrier function in LAR.

